Pacira BioSciences, Inc.

PCRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DFAN14A Jan 9, 2026 AMENDMENT NO. 1
8-K Jan 8, 2026 8-K
4 Jan 6, 2026 FORM 4
4 Jan 6, 2026 FORM 4
4 Jan 6, 2026 FORM 4
4 Jan 6, 2026 FORM 4
144 Jan 5, 2026
SCHEDULE 13D/A Jan 2, 2026
DFAN14A Dec 30, 2025
4 Dec 11, 2025 FORM 4
144 Dec 10, 2025
144 Dec 9, 2025
4 Nov 19, 2025 FORM 4
144 Nov 17, 2025
4 Nov 13, 2025 FORM 4
SCHEDULE 13G/A Nov 13, 2025
SCHEDULE 13D/A Nov 10, 2025
144 Nov 10, 2025
10-Q Nov 6, 2025 10-Q
8-K Nov 6, 2025 8-K
4 Nov 3, 2025 FORM 4
4 Sep 8, 2025 FORM 4
144 Sep 4, 2025
SCHEDULE 13G Aug 13, 2025
4 Aug 11, 2025 FORM 4
← Newer Page 5 of 53 · 1306 filings Older →